https://www.tctmd.com/news/dapa-mi-cardiometabolic-endpoints-win-dapagliflozin-after-acute-mi
0
0
36 words
0
Comments
(UPDATED) The trial had to switch out its hard primary endpoints for a win-ratio analysis: the result was a “soft positive,” one observer said.
You are the first to view
Create an account or login to join the discussion